Apr 14, 2012|
Is all really well with high RoE companies?
In our first article of this series, we introduced the DuPont method as a key technique for analyzing the performance of companies to invest in.
While investors systematically study fundamentals, we highlighted that there can still be gaps in their assessment. The DuPont method focuses on dissecting the important Return on Equity (RoE), and provides invaluable insight regarding the company's strategy, operations and financial health.
Specifically, this DuPont analysis examines the important RoE (Net Profit/Equity) through three components which are:
Put in equation form,
- Operating efficiency, measured by profit margin (Net Profit/Sales)
- Asset use efficiency, measured by total asset turnover (Sales/Total Assets)
- Financial leverage, measured by the equity multiplier
RoE (Return on Equity) = (Net profit margin) * (Asset turnover) * (Equity multiplier) OR
RoE = Net Profit/ Equity = (Net Profit/ Sales) *(Sales/Total Assets) * (Total Assets/Equity)
In today's article we will look at the BSE 500 companies with the highest RoEs to and try and understand the which of the above three drivers largely contributed to the positive results.
BSE Index high RoE companies - A closer look
From the BSE 500 companies, we identified the top 15 with the highest RoEs. The table below, focuses on 7 of these companies, and shows that each of these has different components that drives their RoE.
RoE - Key drivers differ by company
All the numbers are for the year ended 2011
We have used Year ending 2011 numbers to illustrate the value of the DuPont approach. However, investors should consider the past three to five year trends for the RoE and each of its three components.
From the table, FMCG Companies Colgate Palmolive and Hindustan Lever, have the highest RoEs of 132% and 85% respectively (Piramal Healthcare is a special case which we discuss later). These high RoEs are a result of huge asset turnover ratios of 6 and 7 times respectively. Incidentally, these companies also have the highest asset turnover ratios amongst all BSE 500 companies. In general, FMCG companies operate on relatively lower asset bases, and these two companies clearly outperform their peers by "moving" and turning over their goods fast with relatively few assets. It is also likely that FMCG companies are less prone to economic downturns than other industries.
In the table, Nesco and eClerx have the next highest RoEs with 52% and 51% respectively. In their case, it is their net profit margins (33% and 36% respectively) which are the critical contributors to their high RoEs. Their profits seem to be arising from their ongoing business, and do not include any extra ordinary income. If their net profit margin three to five year trend is stable, we can expect consistent RoEs from these companies.
Then, from the table, we see that Tata Motors and Havells India have been able to generate high RoEs of 48% and 46% respectively. And, this performance is driven, not by high profit margins, nor elevated asset turnover, but because of their huge financial leverage. Essentially they have borrowed heavily to support their growth strategy. This also implies that they have a relatively high fixed interest cost obligation, which represents a major risk to these companies. We may recollect here that Tata Motors had acquired Jaguar Land Rover around four years ago, and this dramatically increased its debt obligations.
Piramal Healthcare deserves special mention. For Piramal Healthcare, their huge 513% profit margin resulted in a high RoE figure of 109%. However, know that Piramal's net profits include an extraordinary profit due to the sale of it's healthcare business, and one of its subsidiaries Piramal Diagnostic Services Private Limited. So Piramal Healthcare's 109% RoE is not truly indicative of the company's "health", nor its sustainability.
The DuPont method has provided us with meaningful insights. Each of these companies and their RoEs is driven by a distinctive component. If profit margins are the key, this can connote operational strength and stability. If asset turnover is the main contributing variable, it can be because the company is efficiently using it assets (with good operation and relatively fewer assets). Finally, if financial leverage (equity multiplier) is the core facilitator of RoE, this can indicate a growth strategy undertaken with high risk. Clearly, with the DuPont approach, we know more than just the fundamentals, and now have some answers, and importantly, new questions to help making investment decisions.
Our next article in this series to examine the DuPont method, we will scrutinize BSE companies that have the lowest RoEs. And we will use the DuPont analysis to guide us to understand the reasons behind such low numbers, and if there is "silver" lining somewhere.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 19, 2017
Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.
Aug 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
Aug 18, 2017
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Aug 17, 2017
PersonalFN simplifies the mutual fund account statement for you.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407